SCHEMBL6597916

SCHEMBL6597916

COC(=O)C(C)C(=O)C(C)C(=O)c1cc2ccccc2o1

nearest known ligand 0.56

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TAS1R3 Q7RTX0 3/20 0.56
TAS1R1 Q7RTX1 3/20 0.56
RAB9A P51151 7/20 0.53
NPC1 O15118 6/20 0.53
L3MBTL1 Q9Y468 2/20 0.53
ALDH1A1 P00352 2/20 0.51
LMNA P02545 1/20 0.50
THRB P10828 1/20 0.50
FLT3 P36888 1/20 0.50
SMN1; SMN2 Q16637 5/20 0.49
MAPT P10636 3/20 0.49
TP53 P04637 3/20 0.49
CASP3 P42574 1/20 0.49
SENP7 Q9BQF6 1/20 0.49
TDP1 Q9NUW8 1/20 0.49
MEN1 O00255 4/20 0.48
KMT2A Q03164 4/20 0.48
TSHR P16473 2/20 0.48
HSD17B10 Q99714 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6590654 0.85 ALDH1A1 (0.58) TAS1R3TAS1R1RAB9ANPC1L3MBTL1
SCHEMBL5163106 0.80 ALDH1A1 (0.62) TAS1R3TAS1R1RAB9ANPC1L3MBTL1
SCHEMBL7030373 0.78 FLT3 (0.65) TAS1R3TAS1R1RAB9ANPC1L3MBTL1
SCHEMBL30905600 0.77 ALDH1A1 (0.62) TAS1R3TAS1R1RAB9ANPC1L3MBTL1
SCHEMBL30457810 0.77 ALDH1A1 (0.62) TAS1R3TAS1R1RAB9ANPC1L3MBTL1
Hydrochloric Acid SCHEMBL30905611 0.76 ALDH1A1 (0.61) TAS1R3TAS1R1RAB9ANPC1L3MBTL1
SCHEMBL30905629 0.75 FLT3 (0.61) TAS1R3TAS1R1RAB9ANPC1L3MBTL1
SCHEMBL6753144 0.75 FLT3 (0.53) TAS1R3TAS1R1RAB9ANPC1L3MBTL1
SCHEMBL3529069 0.75 MAPT (0.69) RAB9ANPC1L3MBTL1ALDH1A1FLT3
SCHEMBL30770835 0.75 MAPT (0.69) RAB9ANPC1L3MBTL1ALDH1A1FLT3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1063235-B1 BENZOFURYLPYRONE DERIVATIVES TEIJIN LTD (JP) 2004-05-12 EP disclosed
US-20030186976-A1 Benzofurylpyrone derivatives TEIJIN LIMITED, MICROBIAL CHEMISTRY RESEARCH FOUNDATION 2003-10-02 US disclosed
US-6589984-B1 Blood cholesterol and triglycerides (TG) themselves are generally insoluble in blood, and they exist as lipoproteins by binding with apolipoproteins. In the body, triglycerides are biosynthesized primarily in the liver from acetyl CoA as TEIJIN LIMITED (JP) 2003-07-08 US disclosed
EP-1063235-A1 BENZOFURYLPYRONE DERIVATIVES TEIJIN LIMITED (JP) 2000-12-27 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030186976-A1 Benzofurylpyrone derivatives PLIN5, ACSL5, PLIN1 TAS1R3 2267/4885TAS1R1 1788/4885RAB9A 4399/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.